Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.76 |
| ▸ | CTSD | P07339 | 1/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ALPL | P05186 | 1/20 | 0.59 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31621278 | 1.00 | ALDH1A1 (0.76) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL10477071 | 0.86 | ALDH1A1 (0.57) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6971514 | 0.85 | ALDH1A1 (0.76) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL4694811 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16677831 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8781857 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL962966 | 0.83 | CTSD (1.00) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL417378 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8551670 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL10477073 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240319601-A1 | METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2024-09-26 | — | — | US | claimed |
| US-11981648-B2 | Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones | TESLA, INC. (US) | 2024-05-14 | — | — | US | claimed |
| CN-117597628-A | Method for forming pattern | 三星SDI株式会社 | 2024-02-23 | — | — | CN | claimed |
| US-20240019784-A1 | METAL CONTAINING PHOTORESIST DEVELOPER COMPOSITION, AND METHOD OF FORMING PATTERNS INCLUDING STEP OF DEVELOPING USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2024-01-18 | — | — | US | claimed |
| CN-117348341-A | Metal-containing photoresist developer composition and pattern forming method | 三星SDI株式会社 | 2024-01-05 | — | — | CN | claimed |
| US-20230029852-A1 | METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES | PANASONIC HOLDINGS CORPORATION (JP) | 2023-02-02 | — | — | US | claimed |
| WO-2023003215-A1 | METHOD OF FORMING PATTERNS | 삼성에스디아이 주식회사 | 2023-01-26 | — | — | WO | claimed |
| JP-4041471-A | — | — | None | — | — | JP | disclosed |
| US-20240319601-A1 | METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2024-09-26 | — | — | US | disclosed |
| CN-117597628-A | Method for forming pattern | 三星SDI株式会社 | 2024-02-23 | — | — | CN | disclosed |
| US-20240019784-A1 | METAL CONTAINING PHOTORESIST DEVELOPER COMPOSITION, AND METHOD OF FORMING PATTERNS INCLUDING STEP OF DEVELOPING USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| CN-117348341-A | Metal-containing photoresist developer composition and pattern forming method | 三星SDI株式会社 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023003215-A1 | METHOD OF FORMING PATTERNS | 삼성에스디아이 주식회사 | 2023-01-26 | — | — | WO | disclosed |
| US-20040152309-A1 | Method of polishing a silicon-containing dielectric | CABOT MICROELECTRONICS CORPORATION | 2004-08-05 | — | — | US | disclosed |
| EP-1175406-A1 | IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2002-01-30 | — | — | EP | disclosed |
| CN-1073571-C | Dialkyl tin compound of mononuclear aromatic heterocycle hydroxamate and its synthesis | UNIV SHANXI (CN) | 2001-10-24 | — | — | CN | disclosed |
| CN-1073566-C | Binuclear aromatic, heterocyclic monoacyl hydroxamic acid dialkyl-tin compounds, and method for synthesizing same | UNIV SHANXI (CN) | 2001-10-24 | — | — | CN | disclosed |
| WO-2000066563-A1 | IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2000-11-09 | — | — | WO | disclosed |
| CN-1242369-A | Binuclear aromatic, heterocyclic monoacyl hydroxamic acid dialkyl-tin compounds, and method for synthesizing same | UNIV SHANXI (CN) | 2000-01-26 | — | — | CN | disclosed |
| JP-H0441471-A | PRODUCTION OF 2-NITRO-5-SUBSTITUTED PHENOXY) BENZOHYDROXIMIC ACID DERIVATIVE | MITSUBISHI PETROCHEM CO LTD | 1992-02-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981648-B2 | Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones | CYP4X1, DDO, CYP4B1 | ALDH1A1 269/4885CTSD 3854/4885CYP1A2 20/4885 |
| US-20230029852-A1 | METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES | CYP4X1, DDO, CYP4B1 | ALDH1A1 269/4885CTSD 3854/4885CYP1A2 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.